# VLST Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vlst

- Industry: Biotechnology
- Headquarters: Seattle, US
- Total disclosed funding: $60M
- Latest round: Series B (Jun 14, 2012)
- Investors on record: 9

## About

Founded in 2004 and based in Wisconsin, US, VLST Corporation operates as a biotechnology firm.

## Funding rounds

- Series B, Jun 14, 2012, $5M — ARCH Venture Partners, OVP Venture Partners, Versant Ventures, WRF Capital
- Series B, Jun 16, 2006, $55M — ARCH Venture Partners, OVP Venture Partners, Amgen Ventures, MPM BioImpact, TPG Biotech, MedImmune Ventures, WRF Capital, Accelerator Life Science Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B
- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series B
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series B
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series B
- MedImmune Ventures (https://capitalatlas.ai/funds/medimmune-ventures) — Series B
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series B
- Accelerator Life Science Partners (https://capitalatlas.ai/funds/accelerator-life-science-partners) — Series B
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B